PKCOF(PKCOF)
PKCOF
No analyst ratings available
No analyst price targets available for PKCOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $399.71B | $421.30B | $456.79B | $451.95B | $471.38B |
| Low | $383.70B | $390.16B | $430.57B | $426.01B | $444.32B |
| High | $418.60B | $460.75B | $489.23B | $484.05B | $504.86B |
| EBITDA Avg | $93.88B | $98.95B | $107.29B | $106.15B | $110.71B |
| Low | $90.12B | $91.64B | $101.13B | $100.06B | $104.36B |
| High | $98.32B | $108.22B | $114.91B | $113.69B | $118.58B |
| EBIT Avg | $76.08B | $80.19B | $86.95B | $86.03B | $89.72B |
| Low | $73.04B | $74.26B | $81.96B | $81.09B | $84.57B |
| High | $79.68B | $87.70B | $93.12B | $92.14B | $96.10B |
| Net Income Avg | $37.82B | $28.28B | $31.84B | $32.72B | $35.87B |
| Low | $34.99B | $26.17B | $29.46B | $30.28B | $33.19B |
| High | $41.31B | $30.89B | $34.78B | $35.75B | $39.18B |
| EPS Avg | $202.62 | $151.51 | $170.60 | $175.34 | $192.17 |
| Low | $187.50 | $140.20 | $157.87 | $162.25 | $177.83 |
| High | $221.33 | $165.50 | $186.35 | $191.52 | $209.91 |
| Analysts (Rev / EPS) | 5 / 1 | 6 / 1 | 4 / 1 | 3 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $96.22B | $99.97B |
| Low | $92.67B | $97.89B |
| High | $99.76B | $102.05B |
| EBITDA Avg | $22.60B | $23.48B |
| Low | $21.77B | $22.99B |
| High | $23.43B | $23.97B |
| EBIT Avg | $18.31B | $19.03B |
| Low | $17.64B | $18.63B |
| High | $18.99B | $19.42B |
| Net Income Avg | $6.36B | $9.17B |
| Low | $6.12B | $8.83B |
| High | $6.60B | $9.51B |
| EPS Avg | $34.36 | $49.55 |
| Low | $33.08 | $47.70 |
| High | $35.64 | $51.39 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 |